Gossamer Bio, Inc. (GOSS)
0.3459
-0.02
(-6.51%)
USD |
NASDAQ |
Apr 06, 16:00
0.3457
0.00 (0.00%)
Pre-Market: 09:21
Gossamer Bio SG&A Expense (TTM) : 37.63M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| Artelo Biosciences, Inc. | 5.981M |
| Axsome Therapeutics, Inc. | 570.60M |
| Crinetics Pharmaceuticals, Inc. | 191.33M |